Portola Pharmaceuticals reports second quarter 2015 financial results
Portola Pharma reported a net loss of $58.3 million, or $(1.12) per share, for the 2015 second quarter versus a net loss of $31.4 million, or $(0.76) per share, for the same 2014 quarter. Collaboration revenue was $2.4 million for the 2015 second quarter, the same as the 2014 quarter. August 04, 2015